NDC 71258-022

PYLARIFY

Piflufolastat F-18

PYLARIFY is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Progenics Pharmaceuticals, Inc.. The primary component is Piflufolastat F-18.

• Product ID: 71258-022_0141d6de-1339-485f-9494-2cb6a8115c86
• NDC: 71258-022
• Product Type: Human Prescription Drug
• Proprietary Name: PYLARIFY
• Generic Name: Piflufolastat F-18
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-05-26
• Marketing Category: NDA /
• Application Number: NDA214793
• Labeler Name: Progenics Pharmaceuticals, Inc.
• Substance Name: PIFLUFOLASTAT F-18
• Active Ingredient Strength: 80 mCi/mL
• Pharm Classes: Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 71258-022-01

50 mL in 1 VIAL, MULTI-DOSE (71258-022-01)

• Marketing Start Date: 2021-05-26
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details